Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies
about
sameAs
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulantVTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesLow-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization.The Effects of Intravenous Immunoglobulins in Women with Recurrent Miscarriages: A Systematic Review of Randomised Trials with Meta-Analyses and Trial Sequential Analyses Including Individual Patient DataEfficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome.Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.Current treatment of antiphospholipid syndrome: lights and shadows.Intravenous immunoglobulin G in women with reproductive failure: The Korean Society for Reproductive Immunology practice guidelines.Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical histories.Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndromeIVIG in APS pregnancy.Comparison of the effect of aspirin and heparin with or without intravenous immunoglobulin in treatment of recurrent abortion with unknown etiology: A clinical study.Intravenous immunoglobulin in the management of lupus nephritis.When conventional treatment fails: the role of intravenous immunoglobulin in recurrent pregnancy loss secondary to antiphospholipid syndrome.Systematic review of the literature informing the systemic lupus erythematosus indicators project: reproductive health care quality indicators.Management of obstetric antiphospholipid syndrome.Management of pregnancy in systemic lupus erythematosus.Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.LMWH to prevent placenta-mediated pregnancy complications: an update.The antiphospholipid syndrome: from pathophysiology to treatment.Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.Use of heparin in women with early and late miscarriages with and without thrombophilia.Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.The chequered history of the antiphospholipid syndrome.Effectiveness of high-dose i.v. immunoglobulin therapy for pregnant women with aspirin-heparin-resistant secondary antiphospholipid syndrome.Immune modulation of i.v. immunoglobulin in women with reproductive failure.Intravenous immunoglobulin therapy for aspirin-heparinoid-resistant antiphospholipid syndrome.Management of antiphospholipid syndrome
P2860
Q24247000-31E53911-7CE6-4080-9ACF-8AD49DCB9FF1Q24632982-6BFB7441-D490-4E02-8F96-D9E703F36F84Q24811362-FCE1983F-0C24-4E5F-8453-F1F096A01D61Q26777807-443C4D6A-72E0-4A0D-9DDB-422BEA98A1FBQ33393109-DD0BD7AB-C854-4B74-96F6-1220E61A627FQ33393738-AFD3F274-C1CA-4CDD-A553-7F3F9344C9B3Q33423959-0120FE98-47F0-43B1-A955-AD4212C1C2A4Q33575554-3DEF2137-ECA2-4C42-9646-E10E80C96F47Q34476952-286A2C84-489E-41B9-A55A-816EDD8C5A74Q35169322-34D5817E-EC2F-4BC9-BD70-63BE1447704FQ35751482-AD2A0544-110A-4180-ADEE-2F83CDBFBA91Q35918396-A2301D02-BDBB-4D7B-AA1B-77542EA84F69Q36242493-B7E60502-EE7B-4E2B-92AD-329A674C8A56Q36302368-49FD58C7-EC52-48B9-B965-050B5F472281Q37315277-4D533F34-EE79-4427-BCB3-E786E2CB77DAQ37782039-8E8A04E3-2C05-486D-9FCF-202E5A1D73C3Q37959314-EB3E31CB-6E96-4FF3-BBD5-5976E07ABA6BQ38036105-C0FBC941-B9C9-423A-9787-F525E71C5113Q38092150-C6B0651D-23F1-4709-92EB-3E48090A6E62Q38268419-3D47DF04-7BDD-49BA-824D-5164E9AAF1BBQ38873953-69AD7AC2-54A5-4513-A0BA-86674298BF83Q38876334-F86D5D7A-47C7-43BC-B15F-D81915CA04A8Q43295201-1D1E5B19-E2C5-442E-9DD1-C90DD13204FEQ46179258-5BEDA62A-68CB-4636-8ACC-4DD9EE2E1D8FQ47407572-41641A3F-09F8-44B0-BC16-C25A04057ACAQ48081474-14821975-F566-474E-B70D-953772B78885Q53691739-9F12EB8B-770C-489A-AB48-835152DF4241Q55094703-A29F106F-399E-433E-A0FB-2904D7136547Q55340983-41F5C284-2A1D-425D-8D5E-145E8CB56548Q57656275-8F3F203A-3C45-47D9-998A-1FEC49493B38
P2860
Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Randomized study of subcutaneo ...... th antiphospholipid antibodies
@ast
Randomized study of subcutaneo ...... th antiphospholipid antibodies
@en
Randomized study of subcutaneo ...... th antiphospholipid antibodies
@nl
type
label
Randomized study of subcutaneo ...... th antiphospholipid antibodies
@ast
Randomized study of subcutaneo ...... th antiphospholipid antibodies
@en
Randomized study of subcutaneo ...... th antiphospholipid antibodies
@nl
prefLabel
Randomized study of subcutaneo ...... th antiphospholipid antibodies
@ast
Randomized study of subcutaneo ...... th antiphospholipid antibodies
@en
Randomized study of subcutaneo ...... th antiphospholipid antibodies
@nl
P2093
P50
P356
P1476
Randomized study of subcutaneo ...... th antiphospholipid antibodies
@en
P2093
Antonina Accardo-Palumbo
Antonio Castelli
Giuseppe Licata
P304
P356
10.1002/ART.10957
P407
P577
2003-03-01T00:00:00Z